AAAAAA

   
Results: 1-14 |
Results: 14
INFLUENCE OF PREGNANCY ON THE PHARMACOKINETIC BEHAVIOR AND THE TRANSPLACENTAL TRANSFER OF THE PIPERACILLIN-TAZOBACTAM COMBINATION
Authors: BOURGET P SERTIN A LESNEHULIN A FERNANDEZ H VILLE Y VANPEBORGH P
Citation: P. Bourget et al., INFLUENCE OF PREGNANCY ON THE PHARMACOKINETIC BEHAVIOR AND THE TRANSPLACENTAL TRANSFER OF THE PIPERACILLIN-TAZOBACTAM COMBINATION, European journal of obstetrics, gynecology, and reproductive biology, 76(1), 1998, pp. 21-27
INFLUENCE OF ACUTE-RENAL-FAILURE ON FPIA RAPID SERUM ASSAY OF MIDAZOLAM AND ITS MAIN METABOLITE
Authors: BOUTON V BOURGET P LESNEHULIN A AMSTUTZ P BENAYED M BENHAMOU D DUFIEUX JL GOURSOT G GROBUIS S HABERER JP JARDIN F KIRSTETTER P MARTY J MERCATELLO A PAGE B POURRIAT JL VASSAL T
Citation: V. Bouton et al., INFLUENCE OF ACUTE-RENAL-FAILURE ON FPIA RAPID SERUM ASSAY OF MIDAZOLAM AND ITS MAIN METABOLITE, International journal of clinical pharmacology and therapeutics, 35(11), 1997, pp. 531-538
MONITORING OF TEICOPLANIN IN A MAJOR BURN PATIENT
Authors: LESNEHULIN A BOURGET P LEBEVER H AINAUD P CARSIN H
Citation: A. Lesnehulin et al., MONITORING OF TEICOPLANIN IN A MAJOR BURN PATIENT, Annales francaises d'anesthesie et de reanimation, 16(4), 1997, pp. 374-377
CLINICAL PHARMACOKINETICS OF AMIKACIN-TEI COPLANIN IN INFECTED SEVERELY BURNED PATIENTS - A PILOT-STUDY
Authors: LESNEHULIN A BOURGET P LEBEVER H AINAUD P CARSIN H
Citation: A. Lesnehulin et al., CLINICAL PHARMACOKINETICS OF AMIKACIN-TEI COPLANIN IN INFECTED SEVERELY BURNED PATIENTS - A PILOT-STUDY, Medecine et maladies infectieuses, 27(3), 1997, pp. 306-313
FLUORESCENCE POLARIZATION IMMUNOASSAY - DOES IT ALWAYS REPRESENT A RELIABLE METHOD TO MONITOR TREATMENT WITH TEICOPLANIN - COMPARISON WITH DATA OBTAINED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
Authors: BOURGET P LESNEHULIN A SERTIN A MAILLOT A ALAYA M MARTIN C
Citation: P. Bourget et al., FLUORESCENCE POLARIZATION IMMUNOASSAY - DOES IT ALWAYS REPRESENT A RELIABLE METHOD TO MONITOR TREATMENT WITH TEICOPLANIN - COMPARISON WITH DATA OBTAINED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, International journal of pharmaceutics, 146(2), 1997, pp. 167-174
TRACEABILITY OF BLOOD DERIVATIVE MEDICINA L PRODUCTS - REGULATIONS AND PHARMACO-ECONOMIC IMPLICATIONS AFTER 24 MONTHS OF APPLICATION IN A PARIS TEACHING HOSPITAL
Authors: LESNEHULIN A BOURGET P SILVIE M BARATH V SINGLAS E
Citation: A. Lesnehulin et al., TRACEABILITY OF BLOOD DERIVATIVE MEDICINA L PRODUCTS - REGULATIONS AND PHARMACO-ECONOMIC IMPLICATIONS AFTER 24 MONTHS OF APPLICATION IN A PARIS TEACHING HOSPITAL, Pathologie et biologie, 45(9), 1997, pp. 741-750
PERIOPERATIVE PHARMACOKINETICS OF PIPERACILLIN DURING LIVER-TRANSPLANTATION
Authors: BOURGET P LESNEHULIN A ECOFFEY C LEVAUFRE B
Citation: P. Bourget et al., PERIOPERATIVE PHARMACOKINETICS OF PIPERACILLIN DURING LIVER-TRANSPLANTATION, International journal of clinical pharmacology and therapeutics, 34(12), 1996, pp. 550-554
COMPARISON OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND POLYCLONAL FLUORESCENCE POLARIZATION IMMUNOASSAY FOR THE MONITORING OF MIDAZOLAM IN THE PLASMA OF INTENSIVE-CARE UNIT PATIENTS
Authors: BOURGET P BOUTON V LESNEHULIN A AMSTUTZ P BENAYED M BENHAMOU D DUFIEUX PL GOURSOT G GROSBUIS S HABERER JP JARDIN F KIRSTETTER P MARTY J MERCATELLO A PAGE B POURRIAT JL VASSAL T
Citation: P. Bourget et al., COMPARISON OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND POLYCLONAL FLUORESCENCE POLARIZATION IMMUNOASSAY FOR THE MONITORING OF MIDAZOLAM IN THE PLASMA OF INTENSIVE-CARE UNIT PATIENTS, Therapeutic drug monitoring, 18(5), 1996, pp. 610-619
CLINICAL PHARMACOKINETICS OF PIPERACILLIN-TAZOBACTAM COMBINATION IN PATIENTS WITH MAJOR BURNS AND SIGNS OF INFECTION
Authors: BOURGET P LESNEHULIN A LEREVEILLE R LEBEVER H CARSIN H
Citation: P. Bourget et al., CLINICAL PHARMACOKINETICS OF PIPERACILLIN-TAZOBACTAM COMBINATION IN PATIENTS WITH MAJOR BURNS AND SIGNS OF INFECTION, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 139-145
USEFULNESS AND LIMITATIONS OF SPIRAMYCIN ASSAY IN THE AMNIOTIC-FLUID OF WOMEN ON PREVENTIVE TREATMENT FOR CONGENITAL TOXOPLASMOSIS
Authors: BOURGET P LESNEHULIN A FORESTIER F DESMARIS V DULAC E
Citation: P. Bourget et al., USEFULNESS AND LIMITATIONS OF SPIRAMYCIN ASSAY IN THE AMNIOTIC-FLUID OF WOMEN ON PREVENTIVE TREATMENT FOR CONGENITAL TOXOPLASMOSIS, Therapie, 51(6), 1996, pp. 685-687
STUDY OF THE BIOEQUIVALENCE OF 2 CONTROLLED-RELEASE FORMULATIONS OF MORPHINE
Authors: BOURGET P LESNEHULIN A QUINQUISDESMARIS V
Citation: P. Bourget et al., STUDY OF THE BIOEQUIVALENCE OF 2 CONTROLLED-RELEASE FORMULATIONS OF MORPHINE, International journal of clinical pharmacology and therapeutics, 33(11), 1995, pp. 588-594
CLINICAL PHARMACOKINETICS OF PIPERACILLIN -TAZOBACTAM COMBINATION IN INFECTED MAJOR BURN PATIENTS
Authors: LESNEHULIN A BOURGET P LEREVEILLE R LEBEVER H CARSIN H
Citation: A. Lesnehulin et al., CLINICAL PHARMACOKINETICS OF PIPERACILLIN -TAZOBACTAM COMBINATION IN INFECTED MAJOR BURN PATIENTS, Medecine et maladies infectieuses, 25(3BIS), 1995, pp. 525-533
DISPOSITION OF A NEW RATE-CONTROLLED FORMULATION OF PRAZOSIN IN THE TREATMENT OF HYPERTENSION DURING PREGNANCY - TRANSPLACENTAL PASSAGE OF PRAZOSIN
Authors: BOURGET P FERNANDEZ H EDOUARD D LESNEHULIN A RIBOU F BATONSAINTMLEUX C LELAIDIER C
Citation: P. Bourget et al., DISPOSITION OF A NEW RATE-CONTROLLED FORMULATION OF PRAZOSIN IN THE TREATMENT OF HYPERTENSION DURING PREGNANCY - TRANSPLACENTAL PASSAGE OF PRAZOSIN, European journal of drug metabolism and pharmacokinetics, 20(3), 1995, pp. 233-241
PHARMACOKINETICS OF ANTIMICROBIAL AGENTS IN BURNS PATIENTS
Authors: LESNEHULIN A BOURGET P CARSIN H
Citation: A. Lesnehulin et al., PHARMACOKINETICS OF ANTIMICROBIAL AGENTS IN BURNS PATIENTS, Therapie, 50(6), 1995, pp. 575-586
Risultati: 1-14 |